Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 in Adult Healthy Volunteers
Clinical trial NCT05102136 · COMPLETED
Trial details
- NCT number
- NCT05102136
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2023-04-04
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.